Compare BYFC & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BYFC | STXS |
|---|---|---|
| Founded | 1946 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.4M | 86.4M |
| IPO Year | 2013 | 2004 |
| Metric | BYFC | STXS |
|---|---|---|
| Price | $11.66 | $1.19 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 2.1K | ★ 723.1K |
| Earning Date | 07-28-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.67 |
| EPS | ★ 0.07 | N/A |
| Revenue | $184,000.00 | ★ $29,346,617.00 |
| Revenue This Year | N/A | $6.04 |
| Revenue Next Year | N/A | $33.01 |
| P/E Ratio | $165.71 | ★ N/A |
| Revenue Growth | ★ 18.71 | N/A |
| 52 Week Low | $5.51 | $0.80 |
| 52 Week High | $12.35 | $2.89 |
| Indicator | BYFC | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 63.80 | 61.26 |
| Support Level | $11.76 | $0.95 |
| Resistance Level | $12.27 | $1.97 |
| Average True Range (ATR) | 0.14 | 0.09 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 100.00 | 97.47 |
Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank offers a variety of commercial real estate loan products, services, and depository accounts that support investments in affordable housing, small businesses, and nonprofit community facilities located within low-to-moderate income neighborhoods.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.